thumbnail

Springer Science and Business Media LLC

SCIE-ISI SCOPUS (2006-2023)

  1776-2596

  1776-260X

 

 

Cơ quản chủ quản:  SPRINGER , Springer Paris

Lĩnh vực:
Cancer ResearchOncologyPharmacology (medical)

Các bài báo tiêu biểu

Prognostic Role of PD-L1 Expression in Renal Cell Carcinoma. A Systematic Review and Meta-Analysis
Tập 11 Số 2 - Trang 143-148 - 2016
Roberto Iacovelli, Franco Nolè, Elena Verri, Giuseppe Renne, Chiara Paglino, Matteo Santoni, Maria Cossu Rocca, Palma Giglione, Gaetano Aurilio, Daniela Cullurà, Stefano Cascinu, Camillo Porta
Pulmonary toxicities from targeted therapies: a review
- 2011
Nicholas A. Barber, Apar Kishor Ganti
Axitinib—a selective inhibitor of the vascular endothelial growth factor (VEGF) receptor
Tập 4 Số 4 - Trang 297-305 - 2009
Ronan J. Kelly, Olivier Rixe
Antibody–Drug Conjugates for the Treatment of Solid Tumors: Clinical Experience and Latest Developments
- 2017
Aiko Nagayama, Leif W. Ellisen, Bruce A. Chabner, Aditya Bardia
Anticancer role of MUC1 aptamer–miR-29b chimera in epithelial ovarian carcinoma cells through regulation of PTEN methylation
Tập 7 Số 4 - Trang 217-225 - 2012
Fang Dai, Yi Zhang, Xin Zhu, Nianchun Shan, Yuxiang Chen
Serosal inflammation (pleural and pericardial effusions) related to tyrosine kinase inhibitors
- 2009
Kevin R. Kelly, Ronan T. Swords, Devalingam Mahalingam, Swaminathan Padmanabhan, Francis J. Giles
The Pan-Immune-Inflammation Value in Patients with Metastatic Melanoma Receiving First-Line Therapy
Tập 16 - Trang 529-536 - 2021
Giovanni Fucà, Teresa Beninato, Marta Bini, Laura Mazzeo, Lorenza Di Guardo, Carolina Cimminiello, Giovanni Randon, Giulia Apollonio, Ilaria Bisogno, Marta Del Vecchio, Claudia Lauria Pantano, Massimo Di Nicola, Filippo de Braud, Michele Del Vecchio
Since a non-negligible fraction of patients with metastatic melanoma does not experience long-term disease control, even with immunotherapy and targeted therapy, new biomarkers for patient stratification and treatment tailoring are needed in this setting. We investigated the association of a novel immune-inflammatory blood-based biomarker, the Pan-Immune-Inflammation Value (PIV), with clinical out...... hiện toàn bộ
Targeting regulatory T cells
- 2012
Christine Ménétrier‐Caux, Tyler J. Curiel, Julien Faget, Manuarii Manuel, Christophe Caux, Weiping Zou
Concomitant Proton Pump Inhibitors and Outcome of Patients Treated with Nivolumab Alone or Plus Ipilimumab for Advanced Renal Cell Carcinoma
- 2022
Veronica Mollica, Matteo Santoni, Marc Matrana, Umberto Basso, Ugo De Giorgi, Alessandro Rizzo, Marco Maruzzo, Andrea Marchetti, Matteo Rosellini, Sara Bleve, Diana Maslov, Karine Tawagi, Ernest Philon, Zoë Blake, Francesco Massari
Renal toxicity of targeted therapies
- 2009
Ronan J. Kelly, Bertrand Billemont, Olivier Rixe